US 11242380
Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use
granted A61KA61K2039/505A61K2039/54
Quick answer
US patent 11242380 (Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use) held by Takeda Pharmaceutical Company Limited expires Mon Feb 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Feb 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K2039/505, A61K2039/54, A61K39/39591, A61P